Core Viewpoint - The share price of CTO Realty Growth, Inc. significantly declined following allegations from Wolfpack Research regarding misleading statements about dividend sustainability and questionable financial practices [1]. Group 1: Allegations and Investigations - Hagens Berman, a national shareholders rights firm, has initiated an investigation into CTO Realty Growth, Inc. to determine if the company violated securities laws and is urging affected investors to report their losses [2]. - The investigation focuses on CTO's claims of adhering to accounting rules and the use of non-GAAP accounting metrics, particularly concerning the quality of its real estate portfolio and reported asset values [3][5]. Group 2: Financial Distress and Management Practices - Wolfpack Research's report indicates that CTO's management has misrepresented the quality of its properties, revealing that some are in severe financial distress and that the company relies on dilution to cover a $38 million dividend shortfall [4]. - The report criticizes CTO's definition of Adjusted Funds From Operation (AFFO), claiming it excludes recurring capital expenditures, which is not consistent with industry peers, and suggests that management's compensation is inflated based on this metric [5]. Group 3: Whistleblower Information - Whistleblowers with non-public information about CTO Realty Growth are encouraged to assist in the investigation, with potential rewards under the SEC Whistleblower program for original information leading to successful recovery [6].

SAN FRANCISCO, June 23, 2025 (GLOBE NEWSWIRE) -- On June 23, 2025 investors in Hims & Hers Health, Inc. (NYSE: HIMS) saw the price of their shares crash over 30% after Novo Nordisk announced that it terminated its collaboration with the telehealth company due to concerns about Hims & Hers’ sales and “deceptive” marketing of the weight loss drug Wegovy®. This news has prompted national shareholders rights firm Hagens Berman to open an investigation into possible violations of the securities laws. The firm ur ...

NEW YORK, June 23, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Iovance Biotherapeutics, Inc. (NASDAQ: IOVA). Shareholders who purchased shares of IOVA during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/iovance-biotherapeutics-inc-loss-submission-form/? id=153664&from=4 DEAD ...

NEW YORK, June 20, 2025 (GLOBE NEWSWIRE) -- Scott+Scott Attorneys at Law LLP (“Scott+Scott”), a shareholder and consumer rights litigation firm, is investigating whether Compass Diversified Holdings (“Compass” or the “Company”) (NYSE: CODI) or certain of its officers and directors issued misleading and false statements and/or failed to disclose information material to investors in violation of federal securities laws. CLICK HERE TO RECEIVE ADDITIONAL INFORMATION ABOUT THIS POTENTIAL CLASS ACTION Compass own ...

Core Viewpoint - The Gross Law Firm is notifying shareholders of Strategy Incorporated (NASDAQ: MSTR) about a class action lawsuit related to misleading statements regarding the company's bitcoin investment strategy and treasury operations [1][2]. Group 1: Class Action Details - The class period for the lawsuit is from April 30, 2024, to April 4, 2025 [2]. - Allegations include that the company overstated the anticipated profitability of its bitcoin-focused strategy and understated the risks associated with bitcoin's volatility [2]. - Shareholders are encouraged to register for the class action by July 15, 2025, to potentially become lead plaintiffs [3]. Group 2: Law Firm's Mission - The Gross Law Firm aims to protect investors' rights against deceit, fraud, and illegal business practices [4]. - The firm is committed to ensuring companies engage in responsible business practices and good corporate citizenship [4].

Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of Strategy Incorporated (NASDAQ: MSTR) regarding a class action lawsuit due to alleged misleading statements related to the company's bitcoin investment strategy and treasury operations [1][3]. Summary by Relevant Sections Class Period and Allegations - The class period for the lawsuit is from April 30, 2024, to April 4, 2025 [3]. - Allegations include that the company overstated the anticipated profitability of its bitcoin-focused investment strategy and treasury operations, understated the risks associated with bitcoin's volatility, and failed to disclose potential losses from its digital assets following the adoption of ASU 2023-08 [3]. Deadlines and Next Steps for Shareholders - Shareholders are encouraged to register for the class action by the deadline of July 15, 2025 [4]. - Once registered, shareholders will be enrolled in a portfolio monitoring software to receive updates on the case [4]. Law Firm's Mission and Commitment - The Gross Law Firm aims to protect the rights of investors who have suffered due to deceit, fraud, and illegal business practices, ensuring companies adhere to responsible business practices [5].

Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of NET Power, Inc. regarding a class action lawsuit due to allegations of misleading statements and failure to disclose critical information related to Project Permian [1]. Group 1: Allegations - The complaint alleges that NET Power was unlikely to complete its first utility-scale plant, Project Permian, on schedule and that the project would be significantly more expensive than previously represented due to supply chain issues and site-specific challenges [1]. - Defendants' projections regarding the time and capital needed to complete Project Permian were deemed unrealistic [1]. - The increased time and capital requirements for Project Permian are likely to negatively impact the company's business and financial results [1]. - Public statements made by the defendants were materially false and misleading throughout the relevant period [1]. Group 2: Class Action Details - The class period for the lawsuit is from June 9, 2023, to March 7, 2025 [1]. - Shareholders are encouraged to register for the class action by June 17, 2025, to potentially be appointed as lead plaintiffs [2]. - Once registered, shareholders will receive updates through a portfolio monitoring software regarding the case's progress [2]. Group 3: Law Firm Background - The Gross Law Firm is a nationally recognized class action law firm dedicated to protecting investors' rights against deceit and illegal business practices [3]. - The firm aims to ensure companies adhere to responsible business practices and seeks recovery for investors who suffered losses due to misleading statements [3].

Company Overview - Cable One, Inc. is a broadband communications provider offering high-speed internet, video, and voice services through its brands, including Sparklight, Fidelity, Hargray, and CableAmerica [3] Allegations and Financial Performance - On May 1, 2025, Cable One reported first-quarter earnings that significantly fell short of analyst expectations and announced plans to suspend its anticipated dividend [4] - Analysts from KeyBanc and Raymond James raised concerns about the company's credibility, noting that the results contradicted prior management statements forecasting growth in subscribers and broadband revenue [4] Market Reaction - Following the earnings report, Cable One's stock price dropped by $109.48 per share, or 41.79%, closing at $152.51 per share on May 2, 2025 [5]

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against Zenas BioPharma, Inc. due to allegations of violations of federal securities laws related to misleading statements about the company's financial status and operational funding [3][5]. Group 1: Legal Investigation - The firm is reminding investors of the June 16, 2025 deadline to seek the role of lead plaintiff in a federal securities class action against Zenas [3]. - The complaint alleges that Zenas BioPharma overstated its ability to fund operations with existing cash and expected IPO proceeds, leading to materially false and misleading public statements [5]. Group 2: Investor Communication - Faruqi & Faruqi encourages investors who suffered losses in Zenas to contact them directly to discuss their legal options [1]. - The firm is also seeking information from whistleblowers, former employees, and shareholders regarding Zenas' conduct [7].

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against Canopy Growth Corporation due to allegations of violations of federal securities laws related to misleading statements and undisclosed costs impacting financial results [3][5]. Group 1: Legal Investigation and Class Action - A federal securities class action has been filed against Canopy Growth, with a deadline of June 3, 2025, for investors to seek the role of lead plaintiff [3]. - Investors who suffered losses from Canopy Growth between May 30, 2024, and February 6, 2025, are encouraged to discuss their legal options with Faruqi & Faruqi [1][3]. Group 2: Financial Performance and Allegations - The complaint alleges that Canopy Growth and its executives made false or misleading statements regarding the company's financial health, particularly concerning the costs associated with the Claybourne product launch and Storz & Bickel vaporizer devices [5]. - Canopy reported a gross margin decrease of 400 basis points to 32% in Q3 2025, primarily due to costs related to the Claybourne product launch and increased indirect costs [6]. - The company experienced a wider-than-anticipated loss of C$1.11 per share in Q3 2025, compared to the C$0.48 per share loss estimated by analysts [6]. Group 3: Market Reaction - Following the announcement of its financial results, Canopy's share price fell by $0.76, or 27.34%, closing at $2.02 per share on February 7, 2025 [8].